Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of MF59-adjuvanted quadrivalent influenza vaccine in adults aged 65 years and older
2015-000728-27Phase 3Completed
- Sponsor
- CSL Seqirus
- Start
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in influenza comparing aQIV with Boostrix comparator (2 arms). Started Aug 2015; status: completed.
02
Drugs
MF59-adjuvanted quadrivalent influenza vaccineacellular pertussis vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-000728-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000728-27.